SABCS 2022 Conference Coverage
Playback speed
10 seconds
SABCS 2022 Patient-Reported Outcomes From the TROPiCS-02 Trial: The Effect of Sacituzumab Govitecan vs. Chemotherapy in HR+/HER2- mBC
By
SABCS 2022 Conference Coverage
FEATURING
Frederik Marmé
By
SABCS 2022 Conference Coverage
FEATURING
Frederik Marmé
63 views
December 13, 2022
Comments 0
Login to view comments.
Click here to Login
Videos